RENAISSANCE TECHNOLOGIES LLC
Position in HRTX — Heron Therapeutics, Inc. /De/
CIK 1037389
NEW YORK, NY
Position in HRTX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$647,967
-$726,673 QoQ
Shares Held
1,506,900
-12.3% QoQ
Ownership
0.794%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#19
of 161 holders
Holding Since
Mar 2020
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RENAISSANCE TECHNOLOGIES LLC holds $3,952,593,796 across 312 Biotechnology names. HRTX ranks #199 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
13,427,993 | $730,617,099 | |
| 2 | CORT |
Corcept Therapeutics Inc
|
5,261,628 | $457,498,554 | |
| 3 | INCY |
Incyte Corp
|
3,512,132 | $398,135,283 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
320,008 | $158,957,573 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
562,073 | $135,442,730 | |
| 6 | RPRX |
Royalty Pharma plc
|
1,935,800 | $108,540,306 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
1,833,079 | $104,137,217 | |
| 8 | GMAB |
Genmab A/S
|
3,517,850 | $96,635,339 |
All Filings in HRTX
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $647,967 | 1,506,900 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $1,374,640 | 1,718,300 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $2,490,670 | 1,915,900 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $3,597,298 | 2,854,999 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $5,566,931 | 2,689,339 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $5,003,900 | 2,274,500 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $1,818,864 | 1,188,800 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $3,996,314 | 2,008,198 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $6,978,300 | 1,993,800 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $6,665,966 | 2,406,486 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $3,201,610 | 1,883,300 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $300,039 | 291,300 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,228,556 | 1,059,100 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $1,722,662 | 1,140,836 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $816,250 | 326,500 | Shares | Sole | 2023-02-13 | |
| 2021-03-31 | $2,635,746 | 162,600 | Shares | Sole | 2021-05-13 | |
| 2020-09-30 | $1,997,736 | 134,800 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $3,527,458 | 239,800 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $12,349,212 | 1,051,892 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||